Multikinase inhibitor sorafenib transiently promotes necrosis after radiofrequency ablation in rat liver but activates growth signals
Joachim C. Mertens(GastroZentrum Hirslanden Zürich), Andreas Geier(Swiss Integrative Center for Human Health), Beat Müllhaupt(University Hospital of Zurich), Philipp Bruners(RWTH Aachen University), Andreas H. Mahnken(Philipps University of Marburg), Ina V. Martin(University Hospital Zurich), Pascal Frei(University Hospital Zurich), Johannes Schmitt(University Hospital Zurich), Christine Herweg(RWTH Aachen University)
Cited by 26
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
|The Lancet|2019|1.2k